The global insulin market is dominated by three companies: Eli Lilly, the French company Sanofi and the Danish firm Novo Nordisk. In the past decade alone, U.S. insulin list prices…
Tag: Insulin
Pharma’s inexcusable pricing of insulin
A study showing that one in four insulin-treated patients surveyed at an urban US diabetes center were found to be cutting back on insulin use because of cost has been…